Aripiprazole Monotherapy for Maintenance Therapy in Bipolar I Disorder: A 100-Week, Double-Blind Study Versus Placebo
The DOI matches its Crossref record.
Abstract
OBJECTIVE: A 26-week, double-blind, placebo-controlled relapse prevention study of aripiprazole was designed a priori with a prospective, 74-week, double-blind, placebo-controlled extension phase. Efficacy and tolerability of aripiprazole for relapse prevention in bipolar I disorder was, therefore, evaluated for 100 weeks. METHOD: Patients with DSM-IV bipolar I disorder, recent manic or mixed episode, received open-label aripiprazole 15 or 30 mg/day (started at 30 mg/day) for 6 to 18 weeks. Patients achieving stabilization (Young Mania Rating Scale score or= 5% incidence and twice placebo rate) were tremor, akathisia, dry mouth, hypertension, weight gain, vaginitis, abnormal thinking, pharyngitis, and flu syndrome. Mean weight change from baseline to 100 weeks (last observation carried forward) was +0.4 +/- 0.8 kg with aripiprazole and -1.9 +/- 0.8 kg with placebo. CONCLUSIONS: Over a 100-week treatment period, aripiprazole monotherapy was effective for relapse prevention in patients who were initially stabilized on aripiprazole for 6 consecutive weeks, and it maintained a good safety and tolerability profile. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier NCT00036348.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“aripiprazole oral (level 2)375, 376 or once monthly (level 2)377 is also recommended as a first‐line monotherapy in view of its efficacy in preventing any mood or manic episode as well as its safety/tolerability profile, although it has not been shown to be effective in preventing depression.”
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 237
Antipsychotics in the Treatment of Bipolar Disorder
Singh, J. B., Chen, G., & Canuso, C. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_8 · Cited by 31
Mazza, M., Squillacioti, M. R., Pecora, R. D., Janiri, L., & Bria, P. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802504490 · Cited by 26
Walpoth, M., Kemmler, G., Grunze, H., Wei, U., Hörtnagl, C., Strau, R., Blasko, I., & Hausmann, A. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328356ac92 · Cited by 28
Economic evaluations in bipolar disorder: a systematic review and critical appraisal
Pari, A. A. A., Simon, J., Wolstenholme, J. L., Geddes, J. R., & Goodwin, G. M. (2014) · Bipolar Disorders · doi:10.1111/bdi.12213 · Cited by 26
State of the Art: Treatment of Bipolar Disorders
Severus, E., Schaaff, N., & Möller, H. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00258.x · Cited by 23
Long-acting risperidone: a review of its role in the treatment of bipolar disorder
Kemp, D. E., Canan, F., Goldstein, B. I., & McIntyre, R. S. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0039-0 · Cited by 27
A UK consensus on the administration of aripiprazole for the treatment of mania
Aitchison, K. J., Bienroth, M., Cookson, J., Gray, R. J., Haddad, P. M., Moore, B. A., Ratna, L., Sullivan, G., Taylor, D. M., Taylor, M., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108098820 · Cited by 23
An overview of pharmacotherapy for bipolar I disorder
Morsel, A., Morrens, M., & Sabbe, B. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1426746 · Cited by 24
Fazio, P. D., Girardi, P., Maina, G., Mauri, M. C., Mauri, M., Monteleone, P., Perini, G., Perugi, G., & Rossi, A. (2010) · Clinical Drug Investigation · doi:10.2165/11584270-000000000-00000 · Cited by 22
Fagiolini, A. M., Brugnoli, R., Sciascio, G. D., Filippis, S. D., & Maina, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1013029 · Cited by 23
A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium
Gentile, S. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.951325 · Cited by 23
Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis
Fountoulakis, K. Ν., Gonda, X., Vieta, E., & Schmidt, F. M. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-27 · Cited by 22
Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Fountoulakis, K. Ν., Gonda, X., Vieta, E., & Rihmer, Z. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-8 · Cited by 23
Cipriani, A., Barbui, C., Rendell, J., & Geddes, J. R. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12223 · Cited by 20
The Contemporary Face of Bipolar Illness:Complex Diagnostic and Therapeutic Challenges
Fountoulakis, K. Ν. (2008) · CNS Spectrums · doi:10.1017/s1092852900013894 · Cited by 23
A Chromatographic Determination of Aripiprazole using HPLC and UPLC: A Comparative Validation Study.
Thakkar, R., Saravaia, H. T., Ambasana, M. A., Kaila, H. O., & Shah, A. K. (2011) · Europe PMC (PubMed Central) · doi:10.4103/0250-474x.95638 · Cited by 19
Is Monotherapy as Good as Polypharmacy in Long—Term Treatment of Bipolar Disorder?
Alda, M., & Yatham, L. N. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905401101 · Cited by 20
Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder
Azorin, J., & Simon, N. (2019) · Drugs · doi:10.1007/s40265-019-01189-8 · Cited by 22
Bai, Y., Yang, H., Chen, G., & Gao, K. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001169 · Cited by 21
Is there a ‘weight neutral’ second-generation antipsychotic for bipolar disorder?
Fang, F., Wang, Z., Wu, R., Calabrese, J. R., & Gao, K. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1276284 · Cited by 18
Self-citationAntipsychotic Drugs and Dysregulated Glucose Homeostasis: A Systematic Review and Meta-Analysis
Smith, E. C. C., Agarwal, S. M., Panganiban, K. J., Maksyutynska, K., Monteiro, J., Lee, J., Prasad, F., Ji, A., Shah, D., Cavalier, S., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2240 · Cited by 23
Schieber, F. C., Boulton, D. W., Balch, A. H., Croop, R. S., Mallikaarjun, S., Benson, J., & Carlson, B. X. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.999 · Cited by 18
Kim, E., Maclean, R., Ammerman, D., Jing, Y., Pikalov, A., You, M. S., Van-Tran, Q., & L'Italien, G. J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.04.022 · Cited by 18
Calabrese, J. R., Sanchez, R., Jin, N., Amatniek, J. C., Cox, K., Johnson, B. R., Perry, P. P., Hertel, P., Such, P., McQuade, R. D., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.043 · Cited by 22
Self-citationAripiprazole-induced acneiform eruption
Mishra, B., Praharaj, S. K., Prakash, R., & Sinha, V. K. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.02.004 · Cited by 17
Salvi, V., Cerveri, G., Aguglia, A., Calò, S., Corbo, M., Martinotti, G., Serafini, G., Signorelli, M. S., Aguglia, E., Amore, M., et al. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000405 · Cited by 16
Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
McIntyre, R. S., Yoon, J., Jm, J., & Liauw, S. S. L. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13876 · Cited by 18
Practical guidance for prescribing with aripiprazole in bipolar disorder
Fagiolini, A. M. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802341426 · Cited by 16
Current and Emerging Therapies for the Management of Bipolar Disorders
El‐Mallakh, R. S., Elmaadawi, A. Z., Gao, Y., Lohano, K., & Roberts, R. J. (2011) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s4441 · Cited by 15
Atypical antipsychotic tolerability and switching strategies in bipolar disorder
Liauw, S. S. L., & McIntyre, R. S. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.510835 · Cited by 18
Pharmacological treatment of mixed states
Cuomo, A., Nikolova, V. L., Yalin, N., Arnone, D., Fagiolini, A., & Young, A. H. (2017) · CNS Spectrums · doi:10.1017/s1092852917000013 · Cited by 14
Improving the design of maintenance studies for bipolar disorder
Gitlin, M. J., Abulseoud, O. A., & Frye, M. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.489830 · Cited by 14
When to start aripiprazole therapy in patients with bipolar mania
Grunze, H., Sayyaparaju, K. K., & Fountoulakis, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s40066 · Cited by 13
Aripiprazole for the treatment of bipolar disorder: a review of current evidence
Fagiolini, A. M., Nitti, M. P., Forgione, R. N., Marra, F. S., & Casamassima, F. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.552429 · Cited by 12
Buoli, M., Esposito, C. M., Godio, M., Caldiroli, A., Serati, M., & Altamura, A. C. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117705098 · Cited by 12
Aripiprazole-induced Asymptomatic Hypertension: A Case Report
Seven, H., Ayhan, M. G., Kürkcü, A., Özbek, S., & Eren, İ. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4362 · Cited by 12
Keramatian, K., Chakrabarty, T., Saraf, G., & Yatham, L. N. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01252-w · Cited by 12
Long-Term Treatment of Mood Disorders
Nolen, W. A., & Grunze, H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00004-x · Cited by 12
Surace, T., Capuzzi, E., Caldiroli, A., Ceresa, A., Esposito, C. M., Auxilia, A. M., Tagliabue, I., Capellazzi, M., Legnani, F., Paolo, M. D., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12092215 · Cited by 12
Evaluating aripiprazole as a potential bipolar disorder therapy for adults
Moro, M. F., & Carta, M. G. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.971152 · Cited by 11
Goldberg, J. F. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20190005 · Cited by 12
First manic episode in a 55-year-old man after initiation of aripiprazole.
Donohue, A. (2010) · PubMed · Cited by 10
Uribe, E. S., Mendoza, A. D. G., Díaz‐Anzaldúa, A., Martínez‐Magaña, J. J., Tovilla‐Zárate, C. A., Juárez‐Rojop, I. E., Lanzagorta, N., Escamilla, M., González‐Castro, T. B., López‐Narváez, M. L., et al. (2019) · Brain and Behavior · doi:10.1002/brb3.1249 · Cited by 10
Bipolar Bozuklukta Koruyucu Tedavi
Eroğlu, M. Z., & Özpoyraz, N. (2010) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.50741 · Cited by 28
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance
Goodwin, G. M., Abbar, M., Schlaepfer, T. E., Grunze, H., Licht, R. W., Bellivier, F., Fountoulakis, K. Ν., Altamura, A. C., Pitchot, W., Ågren, H., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.628380 · Cited by 10
Bipolar (Manic Depressive) Disorders
El‐Mallakh, R. S., & Bauer, M. S. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch49 · Cited by 10
Korean Medication Algorithm for Bipolar Disorder 2010: Introduction
Minkyungjoon, Bahk, W., Yoon, B.-H., Kim, W. K., 김병수, Lee, J. G., Joo, Y. H., Seo, J., Lee, E. M., Ahn, Y.-M., et al. (2011) · 대한정신약물학회지 · Cited by 10
Umene‐Nakano, W., Yoshimura, R., Okamoto, T., Hori, H., & Nakamura, J. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.05.002 · Cited by 9
Aripiprazole and Hypertension in Adolescents
Bat‐Pitault, F., & Delorme, R. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0044 · Cited by 9
Treatment of bipolar depression
Musetti, L., Grande, C. D., Marazziti, D., & Dell’Osso, L. (2013) · CNS Spectrums · doi:10.1017/s1092852912001009 · Cited by 10
Llorca, P., Samalin, L., Charpeaud, & Lorabi (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s7647 · Cited by 9
New Approaches in the Treatment of Bipolar Depression
Saunders, K., & Goodwin, G. M. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_209 · Cited by 11
Kishi, T., Citrome, L., Sakuma, K., & Iwata, N. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115761 · Cited by 11
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
Muzina, D. J. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3763 · Cited by 9
Veznedaroğlu, B., Dılbaz, N., Uzun, Ö., & Işık, E. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318772712 · Cited by 8
Augusto, M., Greene, M., Touya, M., Sweeney, S. M., & Waters, H. C. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0010 · Cited by 9
Torres-Llenza, V., Lakshmin, P., & Lieberman, D. Z. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s129559 · Cited by 10
Hebbrecht, K., Morrens, M., Neels, H. M., Roosens, L., & Sabbe, B. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1515911 · Cited by 9
Gentile, S. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4167 · Cited by 7
Gao, K., Kemp, D. E., & Calabrese, J. R. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_10 · Cited by 7
Self-citationManagement of Bipolar Depression
Chang, J. S., & Ha, K. (2011) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.85390 · Cited by 8
Surguladze, S. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s7608 · Cited by 6
The modern pharmacopoeia: a return to depressive realism?
Goldberg, J. F. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00632.x · Cited by 6
Clinical practice guidelines for the management of bipolar disorder: 2025 update
Menon, V., Ganesh, R., Deep, R., Sarkhel, S., Goswami, S., Mohapatra, D., Munoli, R. N., Sharma, P., Reddy, M., & Muralidharan, K. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_1186_25 · Cited by 10
Augusto, M., Greene, M., Touya, M., Sweeney, S. M., & Waters, H. C. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0009 · Cited by 5
Ahmed, Z., Subhan, F., Ahmed, S., Rasheed, Q. A., Ahmed, S., Shahid, M. M., & Farooq, S. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1137305 · Cited by 5
Spelber, D., Almeida, J., & Nemeroff, C. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00019-0 · Cited by 5
Predictors of Clinical Recovery in Bipolar Disorders
Fico, G., Anmella, G., Murru, A., & Vieta, E. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_10 · Cited by 6
Chapter 49. Treatment of Bipolar Disorder
Strakowski, S. M., & Keck, P. E. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as49 · Cited by 5
Self-citation[Advances in the treatment of mania: aripiprazole].
Vieta, E., & Franco, C. (2008) · Actas Españolas de Psiquiatría · Cited by 6
A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania
Dratcu, L., Bobmanuel, S., Davies, W. C., Farmer, A., George, M., Rana, T., Singh, M., & Turner, M. R. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2012.709865 · Cited by 5
Frecska, E., Kovacs, A. I., Balla, P., Falussy, L., Ferencz, Á., & Varga, Z. (2012) · PubMed · Cited by 4
Goto, J., Shono, M., Abe, Y., Fujita, Y., Ueda, K., Yoshida, B., & Nabeshima, Y. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12371 · Cited by 5
Critical Appraisal of Biomedical Literature With a Succinct Journal Club Template: The ROOTs Format
Johnson, A. M., Thornby, K., & Ferrill, M. J. (2017) · Hospital Pharmacy · doi:10.1177/0018578717721104 · Cited by 4
An Open-Label Study of Aripiprazole for Methamphetamine Induced Psychosis
Sulaiman, A. H., Gill, J. S., Said, M. A., Habil, M. H., Zainal, N. Z., & Ng, C. G. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120412020813 · Cited by 5
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_16 · Cited by 3
About diagnosis and therapy of bipolar disorder
An, B. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2021121031155 · Cited by 3
Kemp, D. E., Eudicone, J. M., McQuade, R. D., Chambers, J. S., & Baker, R. A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181f0569f · Cited by 4
Chronic Olanzapine, Serotonin Receptors, and Subsequent Serotonin Toxicity
Monte, A. A., & Waksman, J. C. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ef09f8 · Cited by 3
Ziprasidone for maintenance treatment of bipolar I disorder in adults
Dubovsky, S. L., & Dubovsky, A. N. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.563237 · Cited by 5
Llorca, P. (2011) · L Encéphale · doi:10.1016/s0013-7006(11)70055-0 · Cited by 2
How can we classify “mood stabilizers” with different properties?
Kondo, T. (2011) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.2.12 · Cited by 2
Neuroprotection in Bipolar Depression
Aiken, C. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_15 · Cited by 2
Successful Treatment of Tardive Diaphragmatic Flutter in an Elderly Man with Aripiprazole
Chen, Y., Lee, C., Lin, Y. L., Lin, Y., & Sun, I.-W. (2012) · International journal of gerontology · doi:10.1016/j.ijge.2012.11.002 · Cited by 2
Dose-Related Aripiprazole-Induced Acneiform Eruption
Park, H. E., Kim, Y. H., & Lee, J. H. (2023) · Annals of Dermatology · doi:10.5021/ad.21.114 · Cited by 1
Bipolare Störungen (ICD-10 F3)
Schläpfer, T. E., Greil, W., & von Stralendorff, I. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50013-7 · Cited by 1
Aripiprazol: farmacología, eficacia clínica, seguridad y tolerabilidad en el adulto.
Belloso, F. J. D., & Loza, A. S. (2011) · Psiquiatria.com · Cited by 1
Biological Treatment of Mood Disorders
Allan, C. L., Topiwala, A., Ebmeier, K. P., Semple, D. M., & Steele, J. D. (2013) · Wiley eBooks · doi:10.1002/9781118316153.ch6 · Cited by 1
Rapagnani, M. P. (2012) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s7388 · Cited by 1
The use of antipsychotics in maintenance treatment of bipolar disorder
Turner, T. L. (2013) · Mental Health Clinician · doi:10.9740/mhc.n155513 · Cited by 1
Aripiprazole in the acute and maintenance phase of bipolar I disorder
Zupancic, M. L., & Gonzalez (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s22579 · Cited by 2
The role of antipsychotics and mood stabilizers in the treatment of bipolar disorder
Correll, C. U. (2011) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 2
Bipolar Disorder in 10–17 Year Old Patients: Treatment Options and Cautions
Romero, P. A. A. S. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s3084 · Cited by 1
Model Development of Mothering by Women with Bipolar Illness
Lewin, L. C., & Templin, T. (2016) · Issues in Mental Health Nursing · doi:10.3109/01612840.2015.1114058 · Cited by 1
Clinical Trial Design of Maintenance Treatments in Bipolar Disorder
Tohen, M. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-405170-6.00001-4 · Cited by 1
Pharmacological Treatment of the Maintenance Phase of Bipolar Depression: Efficacy and Side Effects
Gao, K., Wu, R., & Calabrese, J. R. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_10 · Cited by 3
Self-citationKumar, P. S., Basak, S. C., & Babu, S. M. (2017) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.080333 · Cited by 1
Bipolar Disorder and Safety Monitoring for Clinicians: A Review of the Evidence and the Implications
Bushe, C., & Tohen, M. F. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch28 · Cited by 1
Bocchetta, A. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch7 · Cited by 1
Drug therapy for bipolar disorder: A review of efficacy evidence
Bourin, M. (2023) · Archives of Depression and Anxiety · doi:10.17352/2455-5460.000085 · Cited by 1
Metadata
- Authors
- Keck, P. E., & Calabrese, J. R.
- Affiliations
- University of Cincinnati (US)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-10-15
- Volume
- 68
- Issue
- 10
- Pages
- 1480-1491
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2087458061
- Cited by
- 238
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 9 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 11 · 2016: 8 · 2015: 10 · 2014: 8 · 2013: 17 · 2012: 25
- FWCI
- 14.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- aripiprazole, bipolar I disorder, relapse prevention, maintenance therapy, monotherapy, manic episodes, mixed states, Young Mania Rating Scale, tolerability, adverse effects, weight change
- MeSH terms
- Aripiprazole, Adult, Bipolar Disorder, Depression, Double-Blind Method, Drug Administration Schedule, Female, Humans, Lorazepam, Male, Piperazines, Prospective Studies, Surveys and Questionnaires, Remission Induction, Severity of Illness Index, Antipsychotic Agents, Quinolones, Prevalence, GABA Modulators, Diagnostic and Statistical Manual of Mental Disorders, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.